-
1
-
-
0028314865
-
Mutation in blood coagulation factor V associated with resistance to activated protein C
-
Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369:64-67.
-
(1994)
Nature
, vol.369
, pp. 64-67
-
-
Bertina, R.M.1
Koeleman, B.P.2
Koster, T.3
Rosendaal, F.R.4
Dirven, R.J.5
De Ronde, H.6
-
2
-
-
0028931717
-
High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)
-
Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 1995; 85:1504-1508.
-
(1995)
Blood
, vol.85
, pp. 1504-1508
-
-
Rosendaal, F.R.1
Koster, T.2
Vandenbroucke, J.P.3
Reitsma, P.H.4
-
3
-
-
0028098210
-
Resistance to activated protein C as a basis for venous thrombosis
-
Svensson PJ, Dahlback B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330:517-522.
-
(1994)
N Engl J Med
, vol.330
, pp. 517-5522
-
-
Svensson, P.J.1
Dahlback, B.2
-
4
-
-
0028910906
-
Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men
-
Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995; 332:912-917.
-
(1995)
N Engl J Med
, vol.332
, pp. 912-917
-
-
Ridker, P.M.1
Hennekens, C.H.2
Lindpaintner, K.3
Stampfer, M.J.4
Eisenberg, P.R.5
Miletich, J.P.6
-
5
-
-
18944407386
-
Factor V Leiden mutation is not a risk factor for myocardial infarction in north-east Turkey
-
Çelik S, Uçar F, Baykan M. Factor V Leiden mutation is not a risk factor for myocardial infarction in north-east Turkey. T Klin J Cardiol 2001; 14:104-106.
-
(2001)
T Klin J Cardiol
, vol.14
, pp. 104-106
-
-
Çelik, S.1
Uçar, F.2
Baykan, M.3
-
6
-
-
0033557905
-
Factor V Leiden is not a risk factor for myocardial infarction among young women
-
Amowitz LL, Komaroff AL, Miletich JP, Ridker PM. Factor V Leiden is not a risk factor for myocardial infarction among young women. Blood 1999; 93:1432-1433.
-
(1999)
Blood
, vol.93
, pp. 1432-1433
-
-
Amowitz, L.L.1
Komaroff, A.L.2
Miletich, J.P.3
Ridker, P.M.4
-
8
-
-
0028951045
-
Premature ischaemic heart disease and the gene for coagulation factor V
-
Van Bockxmeer FM, Baker RI, Taylor RR. Premature ischaemic heart disease and the gene for coagulation factor V [Letter]. Nat Med 1995; 1:185.
-
(1995)
Nat Med
, vol.1
, pp. 185
-
-
Van Bockxmeer, F.M.1
Baker, R.I.2
Taylor, R.R.3
-
9
-
-
0033121115
-
Synergistic effects of prothrombotic polymorphisms and atherogenic factors on the risk of myocardial infarction in young males
-
Inbal A, Freimark D, Modan B, Chetrit A, Matetzky S, Rosenberg N, et al. Synergistic effects of prothrombotic polymorphisms and atherogenic factors on the risk of myocardial infarction in young males. Blood 1999; 33:2186-2190.
-
(1999)
Blood
, vol.33
, pp. 2186-2190
-
-
Inbal, A.1
Freimark, D.2
Modan, B.3
Chetrit, A.4
Matetzky, S.5
Rosenberg, N.6
-
10
-
-
0028806737
-
Evidence against heterozygous coagulation factor V 1619 G → A mutation with resistance to activated protein C being a risk factor for coronary artery disease and myocardial infarction
-
Prohaska W, Mannebach H, Schmidt M, Gleichmann U, Kleesiek K. Evidence against heterozygous coagulation factor V 1619 G → A mutation with resistance to activated protein C being a risk factor for coronary artery disease and myocardial infarction. J Mol Med 1995; 73:521-524.
-
(1995)
J Mol Med
, vol.73
, pp. 521-524
-
-
Prohaska, W.1
Mannebach, H.2
Schmidt, M.3
Gleichmann, U.4
Kleesiek, K.5
-
11
-
-
3442901367
-
Prothrombin 20210GA and factor V Leiden mutations in patients less than 55 years old with myocardial infarction
-
Donmez Y, Kanadasi M, Tanriverdi K, Demir M, Demirtas M, Cayli M, et al. Prothrombin 20210GA and factor V Leiden mutations in patients less than 55 years old with myocardial infarction. Jpn Heart J 2004; 45:505-512.
-
(2004)
Jpn Heart J
, vol.45
, pp. 505-512
-
-
Donmez, Y.1
Kanadasi, M.2
Tanriverdi, K.3
Demir, M.4
Demirtas, M.5
Cayli, M.6
-
12
-
-
0031659086
-
Age as a risk factor for myocardial infarction in Leiden mutation carriers
-
Baranovskaya S, Kudinov S, Fomicheva E, Vasina V, Solovieva D, Khavinson V, Schwartz E. Age as a risk factor for myocardial infarction in Leiden mutation carriers. Mol Genet Metab 1998; 83:155-157.
-
(1998)
Mol Genet Metab
, vol.83
, pp. 155-157
-
-
Baranovskaya, S.1
Kudinov, S.2
Fomicheva, E.3
Vasina, V.4
Solovieva, D.5
Khavinson, V.6
Schwartz, E.7
-
13
-
-
0033537469
-
Poor response to activated protein C as a prominent risk predictor of advanced atherosclerosis and arterial disease
-
Kiechl S, Muigg A, Santer P, Mitterer M, Egger G, Oberhollenzer M, et al. Poor response to activated protein C as a prominent risk predictor of advanced atherosclerosis and arterial disease. Circulation 1999; 99:614-619.
-
(1999)
Circulation
, vol.99
, pp. 614-619
-
-
Kiechl, S.1
Muigg, A.2
Santer, P.3
Mitterer, M.4
Egger, G.5
Oberhollenzer, M.6
-
14
-
-
0028902044
-
Mutation in coagulation factor V associated with resistance to activated protein C in patients with coronary artery disease
-
März W, Seydewitz H, Winkelmann B, Chen M, Nauck M, Witt I. Mutation in coagulation factor V associated with resistance to activated protein C in patients with coronary artery disease. Lancet 1995; 345:526-527.
-
(1995)
Lancet
, vol.345
, pp. 526-527
-
-
März, W.1
Seydewitz, H.2
Winkelmann, B.3
Chen, M.4
Nauck, M.5
Witt, I.6
-
15
-
-
3042811442
-
Prevalence of resistance against activated protein C resulting from factor V Leiden is significantly increased in myocardial infarction: Investigation of 507 patients with myocardial infarction
-
Middendorf K, Göhring P, Huehns TY, Seidel D, Steinbeck G, Nikol S. Prevalence of resistance against activated protein C resulting from factor V Leiden is significantly increased in myocardial infarction: Investigation of 507 patients with myocardial infarction. Am Heart J 2004; 147: 897-904.
-
(2004)
Am Heart J
, vol.147
, pp. 897-904
-
-
Middendorf, K.1
Göhring, P.2
Huehns, T.Y.3
Seidel, D.4
Steinbeck, G.5
Nikol, S.6
-
16
-
-
0030984288
-
Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women
-
Rosendaal FR, Siscovick DS, Schwartz SM, Beverly RK, Psaty BM, Longstreth WT Jr et al. Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood 1997; 89:2817-2821.
-
(1997)
Blood
, vol.89
, pp. 2817-2821
-
-
Rosendaal, F.R.1
Siscovick, D.S.2
Schwartz, S.M.3
Beverly, R.K.4
Psaty, B.M.5
Longstreth Jr., W.T.6
-
17
-
-
0032562254
-
Interaction of coagulation defects and cardiovascular risk factors increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A
-
Doggen CJ, Cats VM, Bertina RM, Rosendaal FR. Interaction of coagulation defects and cardiovascular risk factors increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A. Circulation 1998; 87:1037-1041.
-
(1998)
Circulation
, vol.87
, pp. 1037-1041
-
-
Doggen, C.J.1
Cats, V.M.2
Bertina, R.M.3
Rosendaal, F.R.4
-
19
-
-
0028810738
-
World distribution of factor V Leiden
-
Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346:1133-1134.
-
(1995)
Lancet
, vol.346
, pp. 1133-1134
-
-
Rees, D.C.1
Cox, M.2
Clegg, J.B.3
-
20
-
-
0030955080
-
Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening
-
Ridker PM, Miletich JP, Hennekens CH, Buring JE. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA 1997; 277:1305-1307.
-
(1997)
JAMA
, vol.277
, pp. 1305-1307
-
-
Ridker, P.M.1
Miletich, J.P.2
Hennekens, C.H.3
Buring, J.E.4
-
21
-
-
0031181982
-
The prevalence of factor V Leiden (1691 G → A) mutation in Turkey
-
Gurgey A, Mesci L. The prevalence of factor V Leiden (1691 G → A) mutation in Turkey. Turk J Pediatr 1997; 39:313-315.
-
(1997)
Turk J Pediatr
, vol.39
, pp. 313-315
-
-
Gurgey, A.1
Mesci, L.2
-
22
-
-
0036981213
-
Prothrombotic determinants of coronary atherothrombosis
-
Ruberg FL, Loscalzo J. Prothrombotic determinants of coronary atherothrombosis. Vasc Med 2002; 7:289-299.
-
(2002)
Vasc Med
, vol.7
, pp. 289-299
-
-
Ruberg, F.L.1
Loscalzo, J.2
-
23
-
-
0038683224
-
Prothrombotic and antithrombotic pathways in acute coronary syndromes
-
Selwyn AP. Prothrombotic and antithrombotic pathways in acute coronary syndromes. Am J Cardiol 2003; 91:3H-11H.
-
(2003)
Am J Cardiol
, vol.91
-
-
Selwyn, A.P.1
-
24
-
-
0037219632
-
Potential thrombophilic mutations/polymorphisms in patients with no flow-limiting stenosis after myocardial infarction
-
French JK, Van de Water NS, Sutton TM, Lund M, Gao W, McDowell J, et al. Potential thrombophilic mutations/polymorphisms in patients with no flow-limiting stenosis after myocardial infarction. Am Heart J 2003; 145:118-124.
-
(2003)
Am Heart J
, vol.145
, pp. 118-124
-
-
French, J.K.1
Van De Water, N.S.2
Sutton, T.M.3
Lund, M.4
Gao, W.5
McDowell, J.6
-
25
-
-
0033852836
-
Prevalence of factor V Leiden and prothrombin variant G20210A in patients age < 50 years with no significant stenoses at angiography three to four weeks after myocardial infarction
-
Van de Water NS, French JK, Lund M, Hyde TA, White HD, Browett PJ. Prevalence of factor V Leiden and prothrombin variant G20210A in patients age < 50 years with no significant stenoses at angiography three to four weeks after myocardial infarction. J Am Coll Cardiol 2000; 36:717-722.
-
(2000)
J Am Coll Cardiol
, vol.36
, pp. 717-722
-
-
Van De Water, N.S.1
French, J.K.2
Lund, M.3
Hyde, T.A.4
White, H.D.5
Browett, P.J.6
-
26
-
-
23444436924
-
Arterial and venous thromboembolism with fatal outcome and resistance to activated protein C
-
Lindblad B, Svensson PJ, Dahlback B. Arterial and venous thromboembolism with fatal outcome and resistance to activated protein C [Letter]. Lancet 1994; 343:917.
-
(1994)
Lancet
, vol.343
, pp. 917
-
-
Lindblad, B.1
Svensson, P.J.2
Dahlback, B.3
-
27
-
-
0028110974
-
Myocardial infarction associated with homozygous resistance to activated protein C
-
Holm J, Zöller B, Svensson PJ, Berntorp E, Erhardt L, Dahlbäck B. Myocardial infarction associated with homozygous resistance to activated protein C. Lancet 1994; 344:952-953.
-
(1994)
Lancet
, vol.344
, pp. 952-953
-
-
Holm, J.1
Zöller, B.2
Svensson, P.J.3
Berntorp, E.4
Erhardt, L.5
Dahlbäck, B.6
-
28
-
-
1342311289
-
Myocardial infarction as an initial symptom of antiphospholipid syndrome, factor V Leiden mutation, and hyperhomocysteinemia
-
Dropinski J, Wegrzyn W, Szczeklik W, Krzanowski M. Myocardial infarction as an initial symptom of antiphospholipid syndrome, factor V Leiden mutation, and hyperhomocysteinemia. Pol Arch Med Wewn 2004; 111:63-67.
-
(2004)
Pol Arch Med Wewn
, vol.111
, pp. 63-67
-
-
Dropinski, J.1
Wegrzyn, W.2
Szczeklik, W.3
Krzanowski, M.4
-
29
-
-
0035827416
-
Homozygous form of factor V Leiden mutation as the cause of a myocardial infarction in patient with an unremarkable coronary vascular system?
-
Menge H, Faig HG, Lang A, Fahrenkrog U, Lollgen H. Homozygous form of factor V Leiden mutation as the cause of a myocardial infarction in patient with an unremarkable coronary vascular system? Dtsch Med Wochenschr 2001; 123:684-686.
-
(2001)
Dtsch Med Wochenschr
, vol.123
, pp. 684-686
-
-
Menge, H.1
Faig, H.G.2
Lang, A.3
Fahrenkrog, U.4
Lollgen, H.5
-
30
-
-
1542287360
-
Acute myocardial infarction probably caused by paradoxical embolus in a pregnant woman
-
Agostoni P, Gasparini G, Destro G. Acute myocardial infarction probably caused by paradoxical embolus in a pregnant woman. Heart 2004; 90:e12.
-
(2004)
Heart
, vol.90
-
-
Agostoni, P.1
Gasparini, G.2
Destro, G.3
-
31
-
-
0036109021
-
Coronary thrombosis on patient with the factor V Leiden mutation
-
Corre O, Gueret G, Guard M, Abgrall JF, Arvieux CC. Coronary thrombosis on patient with the factor V Leiden mutation. Ann Fr Anesth Reanim 2002; 21:440-444.
-
(2002)
Ann Fr Anesth Reanim
, vol.21
, pp. 440-444
-
-
Corre, O.1
Gueret, G.2
Guard, M.3
Abgrall, J.F.4
Arvieux, C.C.5
-
32
-
-
18944369845
-
Activated protein C resistance and low molecular weight lipoprotein (a): Dual pathogens, for atherothrombosis?
-
in press
-
Anand S, Kliber A, Koschinsky ML. Activated protein C resistance and low molecular weight lipoprotein (a): dual pathogens, for atherothrombosis? Thrombosis Res 2004; in press.
-
(2004)
Thrombosis Res
-
-
Anand, S.1
Kliber, A.2
Koschinsky, M.L.3
-
33
-
-
0032569645
-
Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease
-
Ray JG. Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease. Arch Intern Med 1998; 158:2101-2106.
-
(1998)
Arch Intern Med
, vol.158
, pp. 2101-2106
-
-
Ray, J.G.1
-
34
-
-
0026034240
-
Thermolabile methylenetetrahydrofolate reductase: An inherited risk factor for coronary artery disease
-
Kang S-S, Wong PWK, Susmano A, Sora J, Norusis M, Ruggie N. Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet 1991; 48:536-545.
-
(1991)
Am J Hum Genet
, vol.48
, pp. 536-545
-
-
Kang, S.-S.1
Wong, P.W.K.2
Susmano, A.3
Sora, J.4
Norusis, M.5
Ruggie, N.6
-
35
-
-
0029049553
-
A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
-
Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10:110-113.
-
(1995)
Nat Genet
, vol.10
, pp. 110-113
-
-
Frosst, P.1
Blom, H.J.2
Milos, R.3
Goyette, P.4
Sheppard, C.A.5
Matthews, R.G.6
-
36
-
-
0031464710
-
Myocardial infarction in a 35-year-old man with homocysteinemia, high plasminogen activator inhibitor activity, and resistance to activated protein C
-
Glueck CJ, Fontaine RN, Gupta A, Alasmi M. Myocardial infarction in a 35-year-old man with homocysteinemia, high plasminogen activator inhibitor activity, and resistance to activated protein C. Metabolism 1997; 46:1470-1472.
-
(1997)
Metabolism
, vol.46
, pp. 1470-1472
-
-
Glueck, C.J.1
Fontaine, R.N.2
Gupta, A.3
Alasmi, M.4
|